Literature DB >> 15213104

Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice.

Ralf Schubert1, Laura Erker, Carrolee Barlow, Hiroyuki Yakushiji, Denise Larson, Angelo Russo, James B Mitchell, Anthony Wynshaw-Boris.   

Abstract

Reactive oxygen species (ROS) are important endogenous etiological agents for DNA damage, and ROS perform critical signaling functions in apoptosis, stress responses and proliferation. The correlation between a lower incidence of cancer in people who consume a diet high in naturally occurring antioxidants and the observed increased ROS in cancerous tissues suggest that antioxidants may be used in cancer chemoprevention. We tested this hypothesis by determining whether the well-described nitroxide antioxidant, tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl), acts as a chemopreventative agent in Atm mutant mice, a model of the human cancer prone syndrome ataxia-telangiectasia. Tempol administered continuously via the diet after weaning resulted in an increased lifespan of these mice by prolonging the latency to thymic lymphomas. Tempol treatment reduced ROS, restored mitochondrial membrane potential, reduced tissue oxidative damage and oxidative stress, consistent with antioxidant effects. In addition, this nitroxide lowered weight gain of tumor prone mice without changes in food intake, metabolism or activity level and exhibited an anti-proliferative effect in vitro. Thus, tempol acts as a novel chemopreventative agent in this mouse model of a human cancer prone syndrome, associated with broad antioxidant effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213104     DOI: 10.1093/hmg/ddh189

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  64 in total

1.  Mitochondrial dysfunction in ataxia-telangiectasia.

Authors:  Yasmine A Valentin-Vega; Kirsteen H Maclean; Jacqueline Tait-Mulder; Sandra Milasta; Meredith Steeves; Frank C Dorsey; John L Cleveland; Douglas R Green; Michael B Kastan
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

Review 2.  Radiological imaging in ataxia telangiectasia: a review.

Authors:  Ishani Sahama; Kate Sinclair; Kerstin Pannek; Martin Lavin; Stephen Rose
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

3.  A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.

Authors:  Andrew Campbell; Brittany Krupp; Jared Bushman; Mark Noble; Christoph Pröschel; Margot Mayer-Pröschel
Journal:  Hum Mol Genet       Date:  2015-08-26       Impact factor: 6.150

4.  ATM directs DNA damage responses and proteostasis via genetically separable pathways.

Authors:  Ji-Hoon Lee; Michael R Mand; Chung-Hsuan Kao; Yi Zhou; Seung W Ryu; Alicia L Richards; Joshua J Coon; Tanya T Paull
Journal:  Sci Signal       Date:  2018-01-09       Impact factor: 8.192

5.  NADPH oxidase 4 is a critical mediator in Ataxia telangiectasia disease.

Authors:  Urbain Weyemi; Christophe E Redon; Towqir Aziz; Rohini Choudhuri; Daisuke Maeda; Palak R Parekh; Michael Y Bonner; Jack L Arbiser; William M Bonner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

6.  Exclusion/confirmation of ataxia-telangiectasia via cell-cycle testing.

Authors:  Tilman Heinrich; Carolin Prowald; Richard Friedl; Benni Gottwald; Reinhard Kalb; Kornelia Neveling; Sabine Herterich; Holger Hoehn; Detlev Schindler
Journal:  Eur J Pediatr       Date:  2006-01-13       Impact factor: 3.183

7.  Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species.

Authors:  Courtney G Havens; Alan Ho; Naohisa Yoshioka; Steven F Dowdy
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

8.  Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.

Authors:  J Pietzner; B M Merscher; P C Baer; R P Duecker; O Eickmeier; D Fußbroich; P Bader; D Del Turco; R Henschler; S Zielen; R Schubert
Journal:  Bone Marrow Transplant       Date:  2016-01-11       Impact factor: 5.483

9.  p53 as a retrovirus-induced oxidative stress modulator.

Authors:  Soo Jin Kim; Paul K Y Wong
Journal:  J Gen Virol       Date:  2014-09-24       Impact factor: 3.891

10.  Antioxidant properties of MitoTEMPOL and its hydroxylamine.

Authors:  Jan Trnka; Frances H Blaikie; Angela Logan; Robin A J Smith; Michael P Murphy
Journal:  Free Radic Res       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.